The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?

More than 25 years after the first peptide receptor radionuclide therapy (PRRT), the concept of somatostatin receptor (SSTR)-directed imaging and therapy for neuroendocrine tumors (NET) is seeing rapidly increasing use. To maximize the full potential of its theranostic promise, efforts in recent yea...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Theranostics
Main Authors: Werner, Rudolf A., Weich, Alexander, Kircher, Malte, Solnes, Lilja B., Javadi, Mehrbod S., Higuchi, Takahiro, Buck, Andreas K., Pomper, Martin G., Rowe, Steven P., Lapa, Constantin
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2018
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299695/
https://ncbi.nlm.nih.gov/pubmed/30613284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.30357
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker